INSIGHTS ON DRUG DEVELOPMENT
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Denaturing SEC-MS Analysis Of High Molecular Weight Impurities
Look at how denaturing SEC‑MS uncovers low‑level oligomers and truncated variants in GLP‑1 peptides, offering clarity on impurity profiles and supporting confident assessment of molecular integrity.
-
Efficiently Optimize Your Workflow With Single-Use Chromatography11/4/2025
Explore how low-volume purification can be done more efficiently in GMP settings with a live system demo and customer insights on optimizing workflows with single-use chromatography.
-
Cost Modeling Analysis Of AAV And LV Manufacturing3/31/2026
Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.
-
Addressing Raw Material Handling Challenges By Dry Granulation8/12/2025
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Method Development For Forced Degradation Of GLP-1 Agonist3/18/2026
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Scale-Up Of A Transient rAAV Production Process11/3/2025
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
DRUG DEVELOPMENT SOLUTIONS
-
Learn more about important considerations in peptides and SEC column separation and a SEC column technology solution.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Malvern 2000 Laser Diffraction Particle Size Analyzer with (1) Malvern Model Scirocco 2000, Dry Power Tray Sampler, and (1) Malvern Model Hydro 2000S, Liquid Test Module.
-
Explore chromatography methods for sample preparation, residual solvent, and impurity analysis, critical steps for Active Pharmaceutical Ingredient (API) quality control.